![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Coulter David M Clark David WJ
Publisher: Informa Healthcare
ISSN: 1474-0338
Source: Expert Opinion on Drug Safety, Vol.3, Iss.6, 2004-11, pp. : 607-614
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 9, 2003-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
COX-2 inhibitors compared and contrasted
By Tavares Ignatius A Bennett Alan
Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 11, 2001-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
COX-2 inhibitors - panacea or paradox?
By Bakhle Y.S.
Trends in Pharmacological Sciences, Vol. 22, Iss. 12, 2001-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
COX-2 inhibitors with a methylsulfoxide pharmacophore
By Chung Shin
Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 5, 2005-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current Status of COX-2 Inhibitors
Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 1, 2008-01 ,pp. :